A nationwide survey of Japanese residents examined the use of generative AI in clinical practice. Approximately 40% of GM-ITE respondents used GenAI, while only 13% relied on it as a primary source of information for differential diagnosis.
This study by a research group at the University of Tokyo Graduate School of Medicine examined the use of GenAI in clinical practice among respondents to the GM-ITE, a basic clinical competency assessment examination for residents in their first or second postgraduate year nationwide. The survey covered 546 hospitals, and an original questionnaire on GenAI use, literacy and perceptions of bedside practice was administered to 2,989 respondents (32.6% of the total) out of 29,389 respondents.
Among all respondents, 1,124 (39.4%) said they used GenAI in clinical work, while 1,726 (60.6%) said they did not. Only 13% relied on GenAI as a primary reference source when making differential diagnoses.